You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glucose Metabolism Diseases

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metabolism Disorder, Glucose, Metabolism Disorder, Lipid, Vitiligo Trial in Xi'an (Collecting blood samples)

Completed
  • Metabolism Disorder, Glucose
  • +2 more
  • Collecting blood samples
  • Xi'an, Shaanxi, China
    Xijing Hospital
Jul 21, 2023

Glucose on Metabolism and Clinical Symptoms of Parkinson's

Recruiting
  • Parkinson Disease
  • +2 more
  • Oral Glucose Tolerance Test
  • Placebo Oral Glucose Tolerance Test
  • Kiel, Germany
    Department for Neurology, University of Kiel
Aug 10, 2023

PreDiabetes, Impaired Glucose Tolerance, Glucose Metabolism Disorders Trial in Venlo (Apple Polyphenols, Control)

Terminated
  • PreDiabetes
  • +2 more
  • Apple Polyphenols
  • Control
  • Venlo, Limburg, Netherlands
    Villa Flora
Jul 18, 2023

Type 2 Diabetes, Glucose Metabolism Disorders, Glucose, High Blood Trial in Bronx (Diazoxide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Nov 11, 2022

Dietary Impact on Continuous Glucose Monitoring

Not yet recruiting
  • Glucose Metabolism Disorders
  • +3 more
    • (no location specified)
    Apr 25, 2023

    Monitoring Sleep, Wellbeing, and Glucose Metabolism in PGY1s

    Recruiting
    • Sleep
    • Glucose Metabolism Disorders
    • CGM
    • +2 more
    • Singapore, (No States Listed), Singapore
      National University of Singapore
    Jan 22, 2023

    Autoimmune Encephalitis Trial in Paris (FDG PET)

    Not yet recruiting
    • Autoimmune Encephalitis
    • FDG PET
    • Paris, France
      Hospital Pitie Salpetriere
    Oct 16, 2023

    Nutrition, Healthy, Dietary Deficiency, Bone Resorption Trial in Palermo (Control Group, Biostimulated group)

    Completed
    • Nutrition, Healthy
    • +5 more
    • Control Group
    • Biostimulated group
    • Palermo, Italy
      NABbio, STEBICEF department
    Jul 30, 2023

    Glucagon-Like Peptide-1 Receptor, Metformin, Obesity, Abdominal Trial in Shanghai (Liraglutide, Semaglutide, Metformin)

    Recruiting
    • Glucagon-Like Peptide-1 Receptor
    • +7 more
    • Shanghai, Shanghai, China
      Ren Ji Hospital, Shanghai Jiao Tong University School of Medicin
    Mar 9, 2023

    Chronic Kidney Diseases, Diabetes, PreDiabetes Trial in Vienna (Therapeutic carbohydrate restriction combined with an

    Recruiting
    • Chronic Kidney Diseases
    • +3 more
    • Therapeutic carbohydrate restriction combined with an SGLT-2-Inhibitor
    • Vienna, Austria
      6th Medical Department with Nephrology and Dialysis, Clinik Otta
    Oct 16, 2023

    Glucose Metabolism Disorders, Health Behavior, Diabetes Trial (Standardized breakfast A, Standardized breakfast B)

    Not yet recruiting
    • Glucose Metabolism Disorders
    • +3 more
    • Standardized breakfast A
    • Standardized breakfast B
    • (no location specified)
    Sep 20, 2023

    Appetitive Behavior, Glucose Metabolism Disorders Trial in London (Splenda drink, Maltodextrin drink, High carbohydrate

    Completed
    • Appetitive Behavior
    • Glucose Metabolism Disorders
    • Splenda drink
    • +2 more
    • London, United Kingdom
      King's College London
    Mar 30, 2023

    Glucose Metabolism Disorders (Including Diabetes) Trial in Lahore (Fenugreek Seeds and Indian Rennet)

    Completed
    • Glucose Metabolism Disorders (Including Diabetes Mellitus)
    • Fenugreek Seeds and Indian Rennet
    • Lahore, Punjab, Pakistan
      University of Management and Technology
    Oct 17, 2023

    Glucose Metabolism Disorders (Including Diabetes), Lipid Metabolism Disorders, Appetitive Behavior Trial in Loughborough (Acute

    Recruiting
    • Glucose Metabolism Disorders (Including Diabetes Mellitus)
    • +2 more
    • Acute oral CBD supplementation
    • Acute oral placebo supplementation
    • Loughborough, Leicestershire, United Kingdom
      Loughborough University
    Jan 16, 2023

    Obesity Trial in Nashville (Oral Glucose Tolerance Test (OGTT), Human Ghrelin, Saline)

    Active, not recruiting
    • Obesity
    • Oral Glucose Tolerance Test (OGTT)
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Nov 18, 2022

    Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Glucose Metabolism Disorders Trial in Aarhus (glucagon)

    Completed
    • Non-Alcoholic Fatty Liver Disease
    • +2 more
    • glucagon
    • Aarhus, Danmark, Denmark
      Aarhus University Hospital
    Nov 3, 2022

    Diabetes, Metabolic Disease, Glucose Metabolism Disorders Trial in Bern (Device: Sokru device)

    Active, not recruiting
    • Diabetes Mellitus
    • +3 more
    • Device: Sokru device
    • Bern, Switzerland
      University of Bern
    Jun 26, 2023

    Brain Metabolism Observed at 7 Tesla

    Recruiting
    • Glut1 Deficiency Syndrome 1
    • +6 more
    • Magnetic resonance imaging
    • Dallas, Texas
      UT Southwestern Medical Center
    Aug 24, 2022

    Cardiometabolic Syndrome, Glucose Metabolism Disorders, Blood Pressure Trial in Olsztyn (Dietary)

    Recruiting
    • Cardiometabolic Syndrome
    • +3 more
    • Dietary
    • Olsztyn, Poland
      University of Warmia and Mazury in Olsztyn
    Mar 7, 2023

    Non-Alcoholic Fatty Liver Disease (NAFLD), Disorders of Glucose Metabolism, Type 2 Diabetes Trial in Shanghai (Intermittent

    Completed
    • Non-Alcoholic Fatty Liver Disease (NAFLD)
    • +3 more
    • Intermittent calorie restriction
    • 25kcal/kg/d diet
    • Shanghai, China
      Zhongshan Hospital, Fudan University
    Aug 5, 2022

    Insulin Sensitivity, Glucose Metabolism Disorders (Including Diabetes), Hyperinsulinism Trial in Maastricht (Two day

    Not yet recruiting
    • Insulin Sensitivity
    • +2 more
    • Two day supplementation of a complex fiber mixture
    • Placebo supplementation
    • Maastricht, Netherlands
    • +1 more
    Mar 1, 2023

    Glucose Metabolism Disorders, Diabetes, Type 2, Hypoglycemic Agents Trial in Karachi (Empagliflozin 10 MG,

    Recruiting
    • Glucose Metabolism Disorders
    • +3 more
    • Empagliflozin 10 MG
    • Insulin+Metformin+DPP4 inhibitor (DPP4I)
    • Karachi, Pakistan
      SINA Shireen Jinnah colony
    Nov 28, 2023

    Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Seoul (Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin)

    Not yet recruiting
    • Dyslipidemias
    • Atherosclerotic Cardiovascular Disease
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Jan 29, 2023

    Exclusive Breastfeeding Improves Puerperal Glucose Metabolism in

    Completed
    • Gestational Diabetes
    • +2 more
    • observe
    • Nanjing, Jiangsu, China
      Nanjing Maternal and child Health Care Hospital
    Nov 27, 2022

    Inactivity, Physical, Aging, Healthy Aging Trial in Toronto (Metabolic Trial, 15 sit-to-stands with calf raises)

    Recruiting
    • Inactivity, Physical
    • +9 more
    • Metabolic Trial
    • 15 sit-to-stands with calf raises
    • Toronto, Ontario, Canada
      Goldring Center for High Performance Sport
    Mar 30, 2023